Abstract:Objective To explore clinical significance of expression of eukaryotic translation initiation factor 4E(eIF4E) and cyclinD1 proteins in the tumorigenesis and progression of colorectal carcinoma.Methods Standard two-step EnVision method of immunohistochemical staining was performed to detect the expression of eIF4E and cyclinD1 proteins in the specimens,including 80 cases of primary colorectal cancer(CRC) surgically resected,20 cases of normal mucosa and 30 cases of colorectal adenoma.Results The positive rates of eIF4E expression in CRC,colorectal adenoma and normal mucosa were 10.0%,83.3%,92.5%,respectively.The expression rates of eIF4E in CRC and colorectal adenoma were significantly higher than those in normal mucosa(P<0.01).eIF4E protein expression in CRC was closely correlated with infiltration depth,lymph node metastasis,TNM stage and 5-year survival(P<0.05).The positive rates of cyclinD1 expression in CRC,colorectal adenoma and normal mucosa were 0,46.7%,55%,respectively.The expression rates of cyclinD1 in CRC and colorectal adenoma were significantly higher than those in normal mucosa(P<0.01).CyclinD1 protein expression in CRC was closely correlated with histological grading(P<0.05),lymph node metastasis and TNM stage(P<0.01).There was a positive relationship between the expression of eIF4E and cyclinD1 in CRC(r=0.914,P<0.01).Conclusion The abnormality of eIF4E expression may be involved in process from adenoma to progressive adenocarcinoma of colorectum,which indicates that eIF4E might play an important role in the tumorigenesis of CRC.CRC with higher expression of eIF4E protein is characterized by deeper infiltration,more lymph node metastasis and worse prognosis,which suggests that eIF4E could be a useful prognostic marker in CRC.elF4E expression in CRC is positively correlated with cyclinD1 expression,which suggests there is a coordinate action between them.

Eukaryotic translation initiation factor 4A1 in the pathogenesis and treatment of cancers

Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers

[Role of Eukaryotic Translation Initiation Factor 4G in Tumor].

Regulation of Eukaryotic Translation Initiation Factor 4E as a Potential Anticancer Strategy

Eukaryotic translation initiation factors and cancer.

Elevated Nuclear Phospho-Eif4e Body Levels Are Associated with Tumor Progression and Poor Prognosis for Acute Myeloid Leukemia

Translational Regulator Eif2α in Tumor

Eukaryotic Translation Initiation Factors and Tumor

Small-Molecule Inhibitors Targeting Eif4a in Leukemia

MiR-144-3p-mediated Dysregulation of EIF4G2 Contributes to the Development of Hepatocellular Carcinoma Through the ERK Pathway

Eukaryotic Translation Initiation Factor 3 and Tumor

Targeting Translation: Eif4e As an Emerging Anticancer Drug Target.

Phospho-eIF4E: a New Target for Acute Myeloid Leukemia.

Eif4e Binding Protein 1 Expression is Associated with Clinical Survival Outcomes in Colorectal Cancer

Research progress in relation between phosphorylation of eIF4E and tumor

High expression of eIF4A1 predicts unfavorable prognosis in clear cell renal cell carcinoma

Translation initiation factors and abnormalities of translation control in tumors

Clinical Significance of eIF4E and CyclinD1 Expression in Primary Colorectal Cancer

Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues.

eIF3a: A new anticancer drug target in the eIF family.

The Regulation of Protein Translation and Its Implications for Cancer